Literature DB >> 25773388

Note of clarification of data in the paper entitled no association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.

Haiyan Yang1, Fuye Shao, Haiyu Wang, Yadong Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25773388     DOI: 10.1007/s13277-015-3234-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


× No keyword cloud information.
  25 in total

1.  Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China.

Authors:  Min Shen; Sonja I Berndt; Nathaniel Rothman; Judy L Mumford; Xingzhou He; Meredith Yeager; Robert Welch; Stephen Chanock; Phouthone Keohavong; Mark Donahue; Tongzhang Zheng; Neil Caporaso; Qing Lan
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

2.  XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.

Authors:  Joachim Schneider; Vera Classen; Ulrike Bernges; Monika Philipp
Journal:  Int J Mol Med       Date:  2005-10       Impact factor: 4.101

3.  DNA repair and cell cycle control genes and the risk of young-onset lung cancer.

Authors:  Stefano Landi; Federica Gemignani; Federico Canzian; Valérie Gaborieau; Roberto Barale; Debora Landi; Neonilia Szeszenia-Dabrowska; David Zaridze; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Lydie Gioia-Patricola; Janet Hall; Paolo Boffetta; Rayjean J Hung; Paul Brennan
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

4.  Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.

Authors:  Kim De Ruyck; Marcin Szaumkessel; Isabelle De Rudder; Annelore Dehoorne; Anne Vral; Kathleen Claes; Anja Velghe; Jan Van Meerbeeck; Hubert Thierens
Journal:  Mutat Res       Date:  2007-04-21       Impact factor: 2.433

5.  DNA repair polymorphisms and cancer risk in non-smokers in a cohort study.

Authors:  G Matullo; A M Dunning; S Guarrera; C Baynes; S Polidoro; S Garte; H Autrup; C Malaveille; M Peluso; L Airoldi; F Veglia; E Gormally; G Hoek; M Krzyzanowski; K Overvad; O Raaschou-Nielsen; F Clavel-Chapelon; J Linseisen; H Boeing; A Trichopoulou; D Palli; V Krogh; R Tumino; S Panico; H B Bueno-De-Mesquita; P H Peeters; E Lund; G Pera; C Martinez; M Dorronsoro; A Barricarte; M J Tormo; J R Quiros; N E Day; T J Key; R Saracci; R Kaaks; E Riboli; P Vineis
Journal:  Carcinogenesis       Date:  2005-11-23       Impact factor: 4.944

6.  8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes.

Authors:  Justyna Janik; Maja Swoboda; Beata Janowska; Jarosław M Cieśla; Daniel Gackowski; Janusz Kowalewski; Ryszard Olinski; Barbara Tudek; Elżbieta Speina
Journal:  Mutat Res       Date:  2011-03-03       Impact factor: 2.433

7.  The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population.

Authors:  Jiaoyang Yin; Ulla Vogel; Yegang Ma; Rong Qi; Zhongfu Sun; Huiwen Wang
Journal:  Lung Cancer       Date:  2007-02-20       Impact factor: 5.705

8.  Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans.

Authors:  Jeffrey S Chang; Margaret R Wrensch; Helen M Hansen; Jennette D Sison; Melinda C Aldrich; Charles P Quesenberry; Michael F Seldin; Karl T Kelsey; John K Wiencke
Journal:  Carcinogenesis       Date:  2008-11-24       Impact factor: 4.944

9.  DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.

Authors:  Senqing Chen; Deliang Tang; Kaixian Xue; Lin Xu; Guojian Ma; Yanzhi Hsu; Stanley S Cho
Journal:  Carcinogenesis       Date:  2002-08       Impact factor: 4.944

10.  The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese.

Authors:  Shujie Guo; Xiaobo Li; Min Gao; Yuqiong Li; Bei Song; Wenquan Niu
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.